secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quantum Cyber N.V. (QUCY)
CIK:        0001874252
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001213900-26-048635
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quantum Cyber N.V. issues $6M preferred shares; David Lazar gains >95% voting control and Co-CEO resigns
--------------------------------------------------------------------------------

- Second closing on Apr 22, 2026: issued Series D/E preferred convertible into up to 225M ordinary shares each, representing >90% fully diluted shares.
- David Lazar becomes controlling shareholder with >95% voting rights; four directors and Co-CEO Guido Baechler resigned; David Natan and Avraham Ben-Tzvi appointed.
- Name changed from Mainz Biomed N.V. to Quantum Cyber N.V.; authorized ordinary shares increased from 45M to 900M, preferred from 5M to 100M.
- All 11 proposals approved at Apr 22 Extraordinary General Meeting, including ratification of board appointments and share issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1874252/000121390026048635/0001213900-26-048635-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1874252/000121390026048635/ea0288083-8k_quantum.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-048635

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer